
Amid tense clashes between NASA and Musk, two NASA science missions launch on SpaceX rocket
After every federal employee received an email asking them to list their recent accomplishments, SpaceX CEO Elon Musk took to his social media platform X, warning any employee who didn't respond would be terminated. NASA, instead, asserted that replying was optional and that its leadership would handle the matter.Two weeks after the clash, the space agency hitched a ride to orbit on a SpaceX rocket.
It's another indicator that, despite an aggressive push by the Trump Administration and Musk to significantly reduce government spending and the federal workforce that have led to some tense public disputes, NASA's space science missions — and its relationship with SpaceX, the dominant launch provider in the U.S. — have so far remained relatively unscathed.
The space agency narrowly escaped the mass firing of its probationary employees and has stayed out of the political crosshairs of Musk's Department of Government Efficiency, which is working to slash funding at agencies like the National Institutes of Health and the Environmental Protection Agency.
It has also survived some strained squabbles with the SpaceX CEO, including Musk's call to deorbit the International Space Station as soon as possible, before its scheduled 2030 decommissioning date.
Yet, tangible threats to the space agency's status quo are looming on the horizon, space-policy experts say, including potentially significant budget cuts and staff reductions through the normal processes of government.
'There's a lot of this highly disruptive, very symbolic culture war … that's taking a lot of attention,' said Casey Dreier, chief of space policy at the Planetary Society, a Pasadena-based nonprofit advocating for space science and exploration. 'But the bigger issue is the more quotidian of, will NASA get the money it needs to do the projects it's told to do.'
SpaceX launched two NASA spacecraft Tuesday — both part of the agency's Explorers Program, designed to provide frequent flight and funding opportunities for space science missions — on its Falcon 9 rocket.
It included a spacecraft from NASA's Jet Propulsion Laboratory in La Cañada Flintridge that will study the rapid expansion that occurred during the first split-second of the universe and a mission from the Southwest Research Institute, a private nonprofit organization based in Texas and Colorado, that will explore the dynamics of solar wind.
Despite the public clashes, a NASA spokesperson said the agency's relationship with Musk's company remains strong.
'NASA is working with partners like SpaceX to build an economy in low Earth orbit and take our next giant leaps in exploration at the Moon and Mars for the benefit of all,' the spokesperson said in a statement. 'To date, NASA invested more than $15 billion in SpaceX for its work under numerous agency contracts.'
The Falcon 9 has become one of the U.S.' most prolific and reliable rides to space (and unlike SpaceX's developmental Starship rocket, it does not frequently explode). Much of the rocket's success is thanks to a nearly two-decade partnership with NASA.
The space agency funded the development of the rocket in 2006 as part of a push to foster a burgeoning private launch industry ahead of the retirement of the Space Shuttle. Two years later, SpaceX was the first private company to reach space with a liquid-fueled rocket, using a scaled-down precursor to the Falcon 9.
In the years since, NASA has given SpaceX billions in contracts to shuttle supplies and, later, astronauts to and from the ISS; launch science missions far beyond Earth's orbit; and now, develop a spacecraft to deorbit the ISS in 2030 and the Starship rocket to carry humans back to the moon.
As SpaceX excelled in rocket development, other private launch companies — and NASA itself — struggled to keep up.
In 2014, NASA awarded Boeing $4.2 billion and SpaceX $2.6 billion to develop capsules to launch astronauts to the ISS. But while SpaceX has launched 10 missions to the ISS with NASA astronauts to date, Boeing has managed only one botched crewed test flight that left two U.S. astronauts on the ISS without a ride back, until SpaceX agreed to take them home.
(Notably, that involved another incident pitting Musk against NASA, in which the former described the astronauts as 'stranded,' despite the latter's insistence that this was a mischaracterization.)
Meanwhile, NASA's Space Shuttle successor, the Space Launch System, has accrued billions in cost overruns and years of delays. The rocket's side boosters and engines were originally projected to cost $7 billion over 14 years of development and flights. That's grown to at least $13.1 billion over 25 years, according to a report from the NASA Office of Inspector General.
The result: Over the years, America's space agency has become increasingly dependent on SpaceX and Musk for access to space.
Then, the Trump administration created DOGE — a temporary organization in the executive office (and not an official government department) — and instated Musk as a special government employee to head it.
The administration began firing probationary employees — government workers in their first year of a new role, who are not yet considered full employees — across the federal government, including at the National Park Service, U.S. Agency for International Development, and most recently, the National Oceanic and Atmospheric Administration.
On Feb. 18, NASA employees braced for a similar cut, but it never came. The agency announced it had worked with the Office of Personnel Management to avoid the firings and that about 5% of the workforce had resigned voluntarily as part of a separate program to reduce the size of the federal workforce.
Instead, the agency began undertaking a longer-term by-the-books reduction of staff mandated by an executive order. The agency, in a document outlining the process, stated it intends to proceed in a manner that 'minimizes adverse impact on employees and limits disruption to critical Agency missions, programs, operations, and organizations.'
The agency is partnering with OPM and DOGE to carry out the reduction and does not have a specific percent reduction goal, a NASA spokesperson said in a statement.
At a Cabinet meeting, Musk said DOGE's goal is not to be 'capricious or unfair' and said the temporary organization has no target numbers. Instead, he wants to keep 'everyone who is doing a job that is essential and doing that job well.'
NASA began the layoffs Monday with 23 employees in advisory science and policy offices, as well as a diversity, equity and inclusion branch.
Employees at JPL, a government contractor funded by NASA but managed by Caltech, are exempt from the reduction, both NASA and JPL confirmed. However, the laboratory remains at the whims of federal funding for its missions.
While, publicly, NASA's science funding has not seen the same level of scrutiny or cuts as other science agencies, Congress has a quick-approaching March 14 budget deadline, and, in line with the White House, the Republican-controlled chambers are set on decreasing federal spending.
The implications for NASA's science programs could be significant.
In an example budget proposal for the 2023 fiscal year, Trump's director of the Office of Management and Budget proposed slashing NASA's science budget in half — which would far outpace previous budget cuts to the agency's science programs.
Typically, NASA's science budget follows the trends of the rest of the discretionary budget, which doesn't include mandatory spending like Medicare and Social Security that is managed outside the typical budget process.
'People love NASA, but in general, NASA's budget doesn't buck the trend of overall non-defense discretionary,' said Dreier. 'If that pie gets bigger, NASA's slice gets a little bigger, but if it gets smaller, NASA's slice doesn't stay big.'
When Congress has tough choices to make over which programs to fund, it's often the science and technology side — and not the human spaceflight side — of the agency that sees the biggest cuts.
Notably — with representatives jockeying to bring funding to their own constituents — conservative-leaning states are home to NASA's biggest human spaceflight centers, like the Kennedy Space Center in Florida and the Johnson Space Center in Texas. More liberal states are home to many of the science-focused centers, like JPL and Maryland's Goddard Space Flight Center, which runs the Explorers Program.
And within the science spending, it's the big flagship science missions, like the James Webb Space Telescope, that survive, whereas smaller missions, like those in the Explorers Program, end up on the chopping block.
The bigger missions often have many more advocates across the country ready to defend the programs, and stir up backlash if they're canceled.
The Senate has yet to hold hearings for Trump's NASA administrator pick, Jared Isaacman, a Musk and SpaceX business partner who rode to space on a Falcon 9 rocket in 2021 as part of the first space mission with an all-civilian crew.
SpaceX did not respond to a request for comment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Steve Wagner's Substack. In this article, we will summarize the bulls' thesis on CHRS. Coherus BioSciences, Inc. (CHRS)'s share was trading at $0.77 as of 30th May. CHRS's trailing P/E was 1.77 according to Yahoo Finance. Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements. Coherus BioSciences (CHRS), long overlooked by Wall Street, is taking a bold step into innovative oncology by partnering with UK-based STORM Therapeutics to test a novel cancer treatment strategy. The collaboration brings together Coherus's immunotherapy toripalimab (LOQTORZI) and STORM's first-in-class RNA-modifying enzyme inhibitor STC-15 in a Phase 1b/2 clinical trial. This unexpected pairing represents a fresh approach to immuno-oncology, targeting cancer through dual mechanisms that could produce synergistic effects. Toripalimab, already approved in the U.S. for nasopharyngeal carcinoma and under review for broader indications, offers proven checkpoint inhibition, while STC-15 introduces a cutting-edge method of disrupting RNA methylation processes linked to tumor growth and immune evasion. If this combo demonstrates efficacy, it could represent a completely new class of cancer therapy and place Coherus at the forefront of next-generation immuno-oncology innovation. Importantly, this partnership shows strategic vision from CHRS's management as they seek to differentiate the company beyond biosimilars and move deeper into proprietary immunotherapy. With the trial still in early stages and little market attention so far, the risk/reward profile for investors is potentially skewed to the upside. Should the data prove positive, the impact could be significant for both companies, especially for CHRS as it repositions itself as a serious player in oncology innovation. This under-the-radar development deserves close monitoring, as it could catalyze a major reevaluation of Coherus's valuation and growth trajectory. Previously, we have covered CHRS in March 2025 wherein we summarized a by the same author. Coherus BioSciences (CHRS) posted a strong turnaround in 2024 with $267M in revenue and $28.5M net income, driven by Loqtorzi's growth and the planned $250M Udenyca divestiture. The company pivoted fully to oncology, trimmed costs, and advanced its pipeline, yet management expressed frustration over the stock's undervaluation, hinting at potential M&A. Since our last coverage, the stock is down 38% as of 30th May. We don't trust CHRS' management as the stock lost more than 95% of its value in recent years and is still losing a ton of money. The market agrees with us and thinks this stock is going to go bankrupt. We believe CHRS should stop wasting shareholder's money, sell valuable assets, and liquidate the company. We don't think that's a likely outcome. Coherus BioSciences, Inc. (CHRS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 10 hedge fund portfolios held CHRS at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of CHRS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
Fox Host Says Trump Is ‘Furious' With Elon Behind the Scenes
President Donald Trump is reportedly seething over Elon Musk's public trashing of his 'Big Beautiful Bill' but knows it's better to keep his mouth shut on the subject for now. The former 'First Buddy' dramatically turned on the president in an unhinged late-night posting spree on Tuesday, labelling his spending plans a 'disgusting abomination' which would 'burden American citizens with crushingly unsustainable debt.' Reacting to the meltdown on Wednesday morning's Fox & Friends, host Brian Kilmeade said: 'I think the Elon Musk thing really caught the president by surprise. And I hear he is furious!' The Fox host frequently has the ear of the president, and his response is a solid indicator of how Trump may respond to Musk's betrayal over the coming days. 'I think he's so smart to keep his powder dry,' Kilmeade added. 'Because it just plays into what critics would have to say, 'The right can't get out of their own way.' 'Instead, you have a goal: Pass it. Elon Musk is not in the Senate or the House. Don't worry about it.' Kilmeade's co-host Lawrence Jones attempted to spin Musk's criticism by suggesting he was still on the president's side, despite his blistering criticisms on Tuesday night. 'I don't think Elon is anti-MAGA now, or anti-the president now,' Jones said. 'He worked so hard, put a lot of stuff on the line to get a lot wasteful stuff cut, and it doesn't sound like Congress is showing that same willingness.' Ainsley Earhardt responded by saying: 'I thought Elon was very respectful in some of the original interviews, saying 'look, we have differences and I don't agree with him on everything.' 'But this latest comment about calling the big, beautiful bill a disgusting abomination, I was shocked to hear him say that I can understand why the president would not be happy about that—this is someone who worked on his team.' Musk's comments have garnered a mixed reception amongst conservative circles. Speaker Mike Johnson rebuked the billionaire and said his comments were 'terribly wrong,' while Sen. Eric Schmitt said: 'We need spending reductions, no doubt. But we're going to work through it.' The former DOGE chief found himself an ally in Rand Paul however, with the Kentucky senator tweeting: 'I agree with Elon. We have both seen the massive waste in government spending and we know another $5 trillion in debt is a huge mistake. We can and must do better.'
Yahoo
42 minutes ago
- Yahoo
Andrew Yang reaches out to Musk to collaborate on new political party
Former Democratic presidential candidate Andrew Yang said he's reached out to Elon Musk in hopes of collaborating on the creation of a new political party, according to a Saturday interview with Politico Magazine. Yang, along with mutual friends, believes the Tesla CEO has what it takes to form a new faction that propels America's strongest leaders. When asked if Musk has responded to his inquiry, Yang told the outlet 'Not yet, but I assume he's been very busy.' 'We have been of the opinion that America needed a new political party for a number of years, and so waiting another 24 hours is nothing,' he added. Musk's push for a new political caucus emerged from his public feud with President Trump over the 'big, beautiful bill.' The tech giant strongly opposed the national debt increase after months of working with the Department of Government Efficiency (DOGE) to cut federal spending. Yang, the founder of 'The Forward Party,' said it's political outsiders like Musk who consider non-traditional approaches to the country's problems. 'I want to work with people that recognize that America's political system has gone from dysfunctional to polarizing to even worse. And at this point, the fastest growing political movement in the United States is independents,' Yang said. 'They feel like neither party represents them, and the two-party system is not delivering what they want to see,' he continued. Many people have recently left the Democratic party, including former White House press secretary Karine Jean-Pierre, who announced she became an independent after seeing political polarization throughout the campaign trail. 'If you look at Musk's politics over the last number of years, he waited in line to meet Barack Obama, he endorsed me in a Democratic cycle, and even earlier in this cycle — 2024 — he was looking for an alternative to Trump,' Yang said. 'There are a number of things that I think Elon shares in common with a lot of other folks I talk to who want to see some kind of middle ground or balance. The problem is: In our two-party system, you get whipsawed either one direction or the other,' he continued. Last year, Musk was a major donor for Republicans but has supported a wide array of candidates like Yang in the past. Now that he's severed ties with the GOP, political hopefuls have been looking to capitalize on the billionaire's powerful funding reserve for future campaigns. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.